BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30878022)

  • 1. Role of Epithelial-Mesenchymal Transition in Tumor Progression.
    Gloushankova NA; Zhitnyak IY; Rubtsova SN
    Biochemistry (Mosc); 2018 Dec; 83(12):1469-1476. PubMed ID: 30878022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherin-mediated cell-cell interactions in normal and cancer cells.
    Gloushankova NA; Rubtsova SN; Zhitnyak IY
    Tissue Barriers; 2017 Jul; 5(3):e1356900. PubMed ID: 28783415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin isoforms and reorganization of adhesion junctions in epithelial-to-mesenchymal transition of cervical carcinoma cells.
    Shagieva GS; Domnina LV; Chipysheva TA; Ermilova VD; Chaponnier C; Dugina VB
    Biochemistry (Mosc); 2012 Nov; 77(11):1266-76. PubMed ID: 23240564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphology, cell-cell interactions, and migratory activity of IAR-2 epithelial cells transformed with the RAS oncogene: contribution of cell adhesion protein E-cadherin].
    Zhitniak IIu; Glushankova NA
    Ontogenez; 2011; 42(6):453-64. PubMed ID: 22288108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
    Lee HM; Hwang KA; Choi KC
    Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
    Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
    Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study.
    Hugo HJ; Kokkinos MI; Blick T; Ackland ML; Thompson EW; Newgreen DF
    Cells Tissues Organs; 2011; 193(1-2):23-40. PubMed ID: 21051859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression.
    Le Bras GF; Taubenslag KJ; Andl CD
    Cell Adh Migr; 2012; 6(4):365-73. PubMed ID: 22796940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A central role for cadherin signaling in cancer.
    Kourtidis A; Lu R; Pence LJ; Anastasiadis PZ
    Exp Cell Res; 2017 Sep; 358(1):78-85. PubMed ID: 28412244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual role of E-cadherin in cancer cells.
    Rubtsova SN; Zhitnyak IY; Gloushankova NA
    Tissue Barriers; 2022 Oct; 10(4):2005420. PubMed ID: 34821540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis.
    Pal M; Bhattacharya S; Kalyan G; Hazra S
    Exp Cell Res; 2018 Jul; 368(2):137-146. PubMed ID: 29674112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An In Vitro System to Study the Epithelial-Mesenchymal Transition In Vitro.
    Gloushankova NA; Rubtsova SN; Zhitnyak IY
    Methods Mol Biol; 2018; 1749():29-42. PubMed ID: 29525988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadherins and epithelial-to-mesenchymal transition.
    Gheldof A; Berx G
    Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting a grip on adhesion: Cadherin switching and collagen signaling.
    Huang H; Wright S; Zhang J; Brekken RA
    Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118472. PubMed ID: 30954569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Plasticity of Cancer Cells Based on Remodeling of the Actin Cytoskeleton and Adhesive Structures.
    Rubtsova SN; Zhitnyak IY; Gloushankova NA
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
    Gasior K; Hauck M; Wilson A; Bhattacharya S
    Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.